We are live on ! Find out more
SILO icon

Silo Pharma

13 hedge funds and large institutions have $285K invested in Silo Pharma in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more capital invested

Capital invested by funds: $162K → $285K (+$123K)

0.1% more ownership

Funds ownership: 0.27%0.37% (+0.1%)

13% less funds holding

Funds holding: 1513 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
3
Closed
6
Calls
Puts
Net Calls
Net Calls Change

SILO Hedge Fund Activity: Q1 2025 in Review

13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q1 2025, worth a combined $285K — up 76% from $162K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of SILO and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was AdvisorShares Investments, opening a new position worth an estimated $185K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $33.4K sold.

  • 13 institutional investors held Silo Pharma (SILO) as of Q1 2025, down from 15 in Q4 2024.
  • Funds reported $285K of Silo Pharma stock for Q1 2025, up 76% quarter-over-quarter.
  • 4 funds opened new Silo Pharma positions in Q1 2025 and 6 closed out, a net change of -2 holders.
  • The largest Silo Pharma buyer in Q1 2025 was AdvisorShares Investments, an estimated $185K added.
  • The largest Silo Pharma seller in Q1 2025 was Renaissance Technologies, an estimated $33.4K sold.

Based on aggregated 13F filings for Q1 2025.